Advanced Radiotherapy (ART) in Gynecological Cancer Patients (GYN-ART)

Local Relapse Free Survival

local control (on the treated site) of the disease

Time frame: From date of radiotherapy end until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 120 months

Regional Relapse Free Survival

regional control (regional lymph nodal chain) of the disease

Time frame: From date of radiotherapy end until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 120 months

Distant Metastases Free Survival

distant metastases developed after the treatment

Time frame: From date of radiotherapy end until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 120 months

Disease Free Survival

absence of disease progression during the follow-up

Time frame: From date of radiotherapy end until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 120 months

Overall Survival

survival from all causes

Time frame: From date of radiotherapy end until the date of death from any cause, assessed up to 120 months

Cancer Specific Survival

cancer survival

Time frame: From date of radiotherapy end until the date of death from disease progression, assessed up to 120 months